Indian Pharmaceutical Market Forecast 2018-2028 - Visiongain Report

Friday, March 2, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, March 2, 2018 /PRNewswire/ --

Forecasts and Analysis by Therapeutic Area (Infectious

Disease, Cardiovascular, Gastrointestinal, Respiratory, Pain Relief / Analgesics, Diabetes, Vitamins/ Minerals/ Nutrients, Dermatology, CNS, Gynaecology, Other), Drug Type (Generic, OTC, Patented, Biosimilar), with Profiles of Leading Companies

Report Details


What can be expected from the Indian Pharmaceutical market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2028, assessing data, trends, opportunities and prospects there.

     (Logo: ) Our 188-page report provides 104 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across the whole of the Indian pharmaceutical market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2018-2028 and other analyses show you commercial prospects Besides revenue forecasting to 2028, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter's Five Forces analysis) and commercial developments.

See revenue forecasts for the leading submarkets and indications How will submarkets perform to 2028? Our study forecasts revenues in the following Indian Pharmaceutical submarkets: • Generic Drugs • Over-The-Counter (OTC) Drugs • Patented Drugs • Biosimilars

See revenue forecasts for the leading therapeutic areas How will leading therapeutic areas perform to 2028? Our study forecasts revenues in therapeutic areas including: • Infectious disease drugs • Cardiovascular disease drugs • Gastro-intestinal drugs • Respiratory disease • Pain relief / analgesics • Diabetes • Vitamins / Minerals / Nutrients • Dermatology • Central Nervous System (CNS) • Gynaecology

Leading companies and potential for market growth Overall revenue for the Indian Pharmaceutical market will reach over $28.7bn in 2018, our work forecasts. We predict strong revenue growth through to 2028. An ageing population, increasing access to healthcare and increasing incidence of chronic diseases, especially diabetes and cardiovascular disease, will drive sales to 2028.

Our work analyses the key companies in the market. See visiongain's analysis of leading companies, including these: • Sun Pharmaceutical Industries Limited • Abbott Healthcare Private Limited (Abbott India) • Cipla Ltd. • Cadila Healthcare Ltd. • GlaxoSmithKline Pharmaceuticals Limited (GSK India) • Pfizer Limited. India • Lupin Pharmaceuticals, Inc.,

A company profile gives you the following information where available: • Discussion of a company's activities and outlook • Historic revenue, analysis and discussion of company performance • Analysis of major products currently on the market • Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the Indian pharmaceutical industry? Our new report discusses issues and events affecting the Indian pharmaceutical market. You will find discussions, including qualitative analyses: • Highly diverse market needing strong knowledge of key therapeutic indications • Changing regulatory landscape challenging new entrants and major market players alike • Emerging drug types with the potential to reshape the market

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Indian Pharmaceutical Market Forecast 2018-2028 report helps you In summary, our 188-page report gives you the following knowledge: • Revenue forecasts to 2028 for the Indian Pharmaceutical market - discover the industry's prospects, finding promising places for investments and revenues • Revenue forecasts to 2028 for each major submarket - discover prospects for leading pharmaceutical products in the following areas: Infectious disease drugs, Cardiovascular disease drugs, Gastro-intestinal drugs, Respiratory disease, Pain relief / analgesics, Diabetes, Vitamins / Minerals / Nutrients, Dermatology, Central Nervous System (CNS), Gynaecology • Revenue forecasts to 2028 for the leading drug types - generics, OTC products, patented drugs and biosimilars • Assessment of leading companies - analysis of products, revenue, mergers & acquisitions, sales by region, therapeutic area and product type • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Molecular Diagnostics market and leading companies. You will find data, trends and predictions. Please order our report now.

To request a report overview of this report please email Sara Peerun at or call Tel: +44-(0)-20-7336-6100

Or click on:

Companies Mentioned in the Report 

Abbott Laboratories

Abbott India

Able Labs

Ajanta Pharma Ltd

Akumentis Healthcare Ltd

Albert David Ltd



Apex Laboratories Pvt. Ltd

Aristo Pharma



Bharat Serums

Biocon Ltd

Bioviz Technologies

Blue Cross Laboratories Ltd.

Cadila Healthcare Ltd.

Cadila Pharmaceuticals Ltd.

Caraco Pharmaceutical Laboratories

Cattern Chemical Inc.


Claris Lifesciences

Daiichi Sankyo

Divis Laboratories

Dr Reddy's Labs

DUSA Pharmaceuticals Inc.


Epirus Biopharmaceuticals

Eris Lifesciences


Fourrts (India) Laboratories Pvt, Ltd

Franco India

Gennova Biopharmaceuticals

Gland Pharma

Glenmark Pharma


GSK India

Hetero Drugs Ltd


Intas Pharma


Ipca Labs


JB Chemicals





Medley Pharmaceuticals Ltd

Medpro Pharmaceutica (Pty) Ltd.

Megafine Pharma

Merck & Co., Inc.

Merck KGaA

Merieux Alliance

Meyer Organics

Micro Labs

MSD Pharma



Novartis India

Pfizer India


Piramal Healthcare

Raptakos, Brett & Co. Ltd

Sandoz (Novartis)


Sanofi India

Serum Institute of India

Shantha Biotechnics

Sun Pharmaceuticals Industries Ltd

Taro Pharmaceutical Industries Ltd.

Teva Pharmaceuticals Ltd.

The Himalaya Drug Company

Torrent Pharma




Virchow Biotech

Wallace + Indi Pharma



Zenotech Laboratories

To see a report overview please email Sara Peerun on

SOURCE Visiongain

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store